Role of surveillance endoscopy, biopsy and biomarkers in early detection of Barrett's adenocarcinoma

Diseases of the Esophagus

Volumn 10, Issue 3, 1997, Pages 165-171

  Ellis Jr , F H ^a   Loda, M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; OMEPRAZOLE;

ARTICLE; BARRETT ESOPHAGUS; CANCER INVASION; CANCER SURVIVAL; CELL CYCLE; CELL PROLIFERATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC APPROACH ROUTE; DIGESTIVE TRACT ENDOSCOPY; EARLY DIAGNOSIS; ESOPHAGUS BIOPSY; FLOW CYTOMETRY; HEALTH CARE COST; HUMAN; PHOTODYNAMIC THERAPY; PREVALENCE; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

EID: 0030865108     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1093/dote/10.3.165     Document Type: Article

References (19)

1. Cameron A J, Zinsmeister A R, Ballard D J, Carney J A. Prevalence of columnar-lined (Barrett's) esophagus: comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918-922.
2. Winters C Jr, Spurling T J, Chobanian S J, et al. Barrett's esophagus: a prevalent occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-124.
3. Streitz J M Jr, Williamson W A, Ellis F H Jr. Current concepts concerning the nature and treatment of Barrett's esophagus and its complications. Ann Thorac Surg 1992; 54: 586-591.
4. Wright T A, Gray M R, Morris A I, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996; 39: 574-579.
5. Williamson W A, Ellis F H Jr, Gibb S P, et al. Barrett's esophagus: prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151:2212-2216.
6. Blot W J, Devesa S S, Kneller R W, Fraumeni J F Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-1289.
7. Reed P I, Johnston B J. The changing incidence of oesophageal cancer. Endoscopy 1993; 25: 606-608.
8. Kirby T J, Rice T W. The epidemiology of esophageal carcinoma: the changing face of a disease. Chest Surg Clin North Am 1994; 4:217-225.
9. Hamilton S R, Smith R R, Cameron J L. Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988; 19:942-948.
10. Schnell T G, Sontag S J, Chejfec G. Adenocarcinoma arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci. 1992; 37: 137-143.
11. Spechler S J, Zeroogian J M, Antonioli D A, Wang H H, Goyal R K. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344: 1533-1536.
12. Cameron A J, Lomboy C T, Pera M, Carpenter H A. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 1541-1546.
13. Reid B J, Haggitt R C, Rubin C E, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19: 166-178.
14. Menke-Pluymers M B. Risk factors for neoplastic progression in Barrett's mucosa. Eur J Surg Oncol 1996; 22: 311-316.
15. Reid B J, Blount P L, Rubin C E, Levine D S, Haggitt R C, Rabinovitch P S. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopie surveillance of a cohort. Gastroenterology 1992; 102: 1212-1219.
16. Hameeteman W, Tytgat G N, Houthoff H J, van den Tweel J G. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96(5 Pt 1): 1249-1256.
17. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991; 32: 1441-1446.
18. Hamilton S R, Smith R R. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987; 87: 301-312.
19. Altorki N K, Sunagawa M, Little A G, Skinner D B. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991; 161:97-99.